GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venus Remedies Ltd (BOM:526953) » Definitions » Stock Based Compensation

Venus Remedies (BOM:526953) Stock Based Compensation : ₹0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Venus Remedies Stock Based Compensation?

Venus Remedies's Stock Based Compensation for the three months ended in Dec. 2023 was ₹0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0 Mil.


Venus Remedies Stock Based Compensation Historical Data

The historical data trend for Venus Remedies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Remedies Stock Based Compensation Chart

Venus Remedies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Venus Remedies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Venus Remedies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.


Venus Remedies Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Venus Remedies's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Venus Remedies (BOM:526953) Business Description

Traded in Other Exchanges
Address
Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids, and others.

Venus Remedies (BOM:526953) Headlines

No Headlines